Suzhou Highfine Biotech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Suzhou Highfine Biotech Co., Ltd.

Why is Suzhou Highfine Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 12.27% and Operating profit at -11.18% over the last 5 years

Flat results in Mar 26

INTEREST(HY) At CNY 0.35 MM has Grown at 316.79%
NET PROFIT(HY) At CNY 45.35 MM has Grown at -38.61%
ROCE(HY) Lowest at 4.83%

With ROE of 4.17%, it has a attractive valuation with a 0.74 Price to Book Value

Over the past year, while the stock has generated a return of 10.05%, its profits have fallen by -25.3%
At the current price, the company has a high dividend yield of 0.8

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Suzhou Highfine Biotech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Suzhou Highfine Biotech Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Suzhou Highfine Biotech Co., Ltd.

12.35%

0.92

41.85%

China Shanghai Composite

19.22%

1.40

13.75%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.27%

EBIT Growth (5y)

-11.18%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.73

Sales to Capital Employed (avg)

0.20

Tax Ratio

13.53%

Dividend Payout Ratio

37.79%

Pledged Shares

Institutional Holding

ROCE (avg)

19.59%

ROE (avg)

11.81%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.74

EV to EBIT

6.33

EV to EBITDA

4.89

EV to Capital Employed

0.53

EV to Sales

1.06

PEG Ratio

Dividend Yield

0.81%

ROCE (Latest)

8.30%

ROE (Latest)

4.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 169.96 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.86 times

NET SALES(Q)

Highest at CNY 171.93 MM

-18What is not working for the Company

INTEREST(HY)

At CNY 0.35 MM has Grown at 316.79%

NET PROFIT(HY)

At CNY 45.35 MM has Grown at -38.61%

ROCE(HY)

Lowest at 4.83%

DEBT-EQUITY RATIO (HY)

Highest at -46.2 %

Here's what is working for Suzhou Highfine Biotech Co., Ltd.

Operating Cash Flow

Highest at CNY 169.96 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Highest at 2.86 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales

Highest at CNY 171.93 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 171.93 MM has Grown at 27.16%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Suzhou Highfine Biotech Co., Ltd.

Interest

At CNY 0.35 MM has Grown at 316.79%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 45.35 MM has Grown at -38.61%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -46.2 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio